Exportar registro bibliográfico


Metrics:

Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial (2012)


Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2021